The last sentence of the “WNV DNA Vaccine, Control Plasmid and E-protein” section of the Materials and Methods should read: “For protein booster vaccine formulation the E-protein was adjuvanted with 10 μg Matrix-M1 adjuvant (Novavax AB, Uppsala, Sweden).”
In addition, the following sentence should be inserted as the last sentence of the “Vaccination Procedures” section of the Materials and Methods: “Mice were boosted four weeks later either via an IM injection of the same does of WNV-DermaVir nanoparticles or via subcutaneous (s.c.) injection of recombinant E-protein () formulated with Matrix-M1 (a kind gift from Novavax AB, Uppsala, Sweden).”
Citation: The PLOS ONE Staff (2014) Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge. PLoS ONE 9(2): e91631. https://doi.org/10.1371/journal.pone.0091631
Published: February 28, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.